A study of radiation-related myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML) patients among Hiroshima atomic bomb survivors showed that 46% of the patients who succumbed to the disease carried point mutations in the RUNX1 gene [3]. This evidence concerns the gene RUNX1 and myelodysplastic syndrome.